These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 2648519

  • 1. Adverse effects of therapy for the correction of anemia in hemodialysis patients.
    Watson AJ.
    Semin Nephrol; 1989 Mar; 9(1 Suppl 1):30-4. PubMed ID: 2648519
    [Abstract] [Full Text] [Related]

  • 2. Clinical efficacy of recombinant human erythropoietin in hemodialysis patients.
    Mohini R.
    Semin Nephrol; 1989 Mar; 9(1 Suppl 1):16-21. PubMed ID: 2648516
    [Abstract] [Full Text] [Related]

  • 3. Overview of anemia associated with chronic renal disease: primary and secondary mechanisms.
    Paganini EP.
    Semin Nephrol; 1989 Mar; 9(1 Suppl 1):3-8. PubMed ID: 2648518
    [Abstract] [Full Text] [Related]

  • 4. Improvements in quality of life following treatment with r-HuEPO in anemic hemodialysis patients.
    Delano BG.
    Am J Kidney Dis; 1989 Aug; 14(2 Suppl 1):14-8. PubMed ID: 2757025
    [Abstract] [Full Text] [Related]

  • 5. Iron deficiency in patients with dialysis-associated anemia during erythropoietin replacement therapy: strategies for assessment and management.
    Van Wyck DB.
    Semin Nephrol; 1989 Mar; 9(1 Suppl 2):21-4. PubMed ID: 2669082
    [Abstract] [Full Text] [Related]

  • 6. Who should receive recombinant human erythropoietin?
    Van Stone JC.
    Semin Nephrol; 1989 Mar; 9(1 Suppl 2):3-7. PubMed ID: 2669084
    [Abstract] [Full Text] [Related]

  • 7. Monitoring considerations in recombinant human erythropoietin therapy.
    Ogden DA.
    Semin Nephrol; 1989 Mar; 9(1 Suppl 2):12-5. PubMed ID: 2669080
    [Abstract] [Full Text] [Related]

  • 8. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
    Phair JP, Abels RI, McNeill MV, Sullivan DJ.
    Arch Intern Med; 1993 Dec 13; 153(23):2669-75. PubMed ID: 8250662
    [Abstract] [Full Text] [Related]

  • 9. [The correction of anemia with a high requirement for transfusion in patients on maintenance hemodialysis by conventional and reduced doses of recombinant human erythropoietin].
    Sivak L, Scuteri RM, Cavalli NH, Gotlieb D, López Blanco OA.
    Medicina (B Aires); 1992 Dec 13; 52(6):516-22. PubMed ID: 1340900
    [Abstract] [Full Text] [Related]

  • 10. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
    Cowgill LD, James KM, Levy JK, Browne JK, Miller A, Lobingier RT, Egrie JC.
    J Am Vet Med Assoc; 1998 Feb 15; 212(4):521-8. PubMed ID: 9491159
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [The treatment of anemia in patients on hemodialysis with recombinant human erythropoietin].
    Borrego FJ, Miguel JL, Zamorano A, Muñoz J, Bajo A, López-Revuelta K, Sánchez Sicilia L.
    Med Clin (Barc); 1991 Nov 23; 97(18):687-92. PubMed ID: 1770818
    [Abstract] [Full Text] [Related]

  • 13. Iron management during recombinant human erythropoietin therapy.
    Van Wyck DB.
    Am J Kidney Dis; 1989 Aug 23; 14(2 Suppl 1):9-13. PubMed ID: 2757026
    [Abstract] [Full Text] [Related]

  • 14. Guidelines for recombinant human erythropoietin therapy.
    Eschbach JW, Adamson JW.
    Am J Kidney Dis; 1989 Aug 23; 14(2 Suppl 1):2-8. PubMed ID: 2667349
    [Abstract] [Full Text] [Related]

  • 15. Comparison of hemodialysis and peritoneal dialysis in the management of anemia related to chronic renal disease.
    Korbet SM.
    Semin Nephrol; 1989 Mar 23; 9(1 Suppl 1):9-15. PubMed ID: 2648520
    [Abstract] [Full Text] [Related]

  • 16. Epoetin: human recombinant erythropoietin.
    Flaharty KK, Grimm AM, Vlasses PH.
    Clin Pharm; 1989 Nov 23; 8(11):769-82. PubMed ID: 2680241
    [Abstract] [Full Text] [Related]

  • 17. Human recombinant erythropoietin treatment in transfusion dependent anemic patients on maintenance hemodialysis.
    Zehnder C, Blumberg A.
    Clin Nephrol; 1989 Feb 23; 31(2):55-9. PubMed ID: 2920469
    [Abstract] [Full Text] [Related]

  • 18. Quality of life: subjective and objective improvements with recombinant human erythropoietin therapy.
    Lundin AP.
    Semin Nephrol; 1989 Mar 23; 9(1 Suppl 1):22-9. PubMed ID: 2648517
    [Abstract] [Full Text] [Related]

  • 19. Recombinant human erythropoietin: impact on brain and cognitive function, exercise tolerance, sexual potency, and quality of life.
    Nissenson AR.
    Semin Nephrol; 1989 Mar 23; 9(1 Suppl 2):25-31. PubMed ID: 2669083
    [Abstract] [Full Text] [Related]

  • 20. Resistance to recombinant human erythropoietin therapy: a real clinical entity?
    Stivelman JC.
    Semin Nephrol; 1989 Mar 23; 9(1 Suppl 2):8-11. PubMed ID: 2669085
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.